Rebus Holdings, Inc. (RBSH)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Rebus Holdings Gross Profit (TTM)
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.02M |
| June 30, 2020 | -0.025M |
| March 31, 2020 | -0.03M |
| December 31, 2019 | -0.035M |
| September 30, 2019 | -0.02M |
| June 30, 2019 | -0.019M |
| March 31, 2019 | -0.019M |
| December 31, 2018 | -0.019M |
| September 30, 2018 | -0.031M |
| June 30, 2018 | -0.04M |
| March 31, 2018 | -0.039M |
| December 31, 2017 | -0.04M |
| September 30, 2017 | -0.028M |
| June 30, 2017 | -0.02M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.022M |
| December 31, 2016 | -0.021M |
| September 30, 2016 | -0.022M |
| June 30, 2016 | -0.022M |
| March 31, 2016 | -0.021M |
| December 31, 2015 | -0.021M |
| September 30, 2015 | -0.02M |
| June 30, 2015 | -0.021M |
| March 31, 2015 | -0.022M |
| December 31, 2014 | -0.023M |
| September 30, 2014 | -0.024M |
| June 30, 2014 | -0.023M |
| March 31, 2014 | -0.024M |
| December 31, 2013 | -0.023M |
| September 30, 2013 | -0.0229M |
| June 30, 2013 | -0.0229M |
| March 31, 2013 | -0.021M |
| December 31, 2012 | -0.021M |
| September 30, 2012 | -0.0202M |
| June 30, 2012 | -0.0202M |
| March 31, 2012 | -0.0202M |
| December 31, 2011 | -0.0202M |
| September 30, 2011 | -0.0206M |
| June 30, 2011 | -0.0155M |
| March 31, 2011 | -0.0151M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |
| Vericel Corp. | 228.38M |